Back to Search Start Over

Belantamab mafodotin (belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study update.

Details

Language :
English
ISSN :
0732183X
Volume :
41
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
164017367
Full Text :
https://doi.org/10.1200/JCO.2023.41.16_suppl.e20046